14 Current news of Biotage
rss06-06-2011
Biotage announced a collaborative research agreement with The Laboratory of Peptide & Protein Chemistry & Biology (PeptLab) located in Florence, Italy. The peptide research facility, led by Professor Anna Maria Papini, has agreed to contribute technical input towards the future development of ...
04-21-2010
Biotage announced it has recently been awarded U.S. patent 7686959: Control system and Method for Flash Separation. The patented technology converts thin-layer chromatography (TLC) compound retention data into a linear gradient and also provides the user with sample loading estimates for any ...
12-18-2009
Biotage is expanding its direct sales coverage and will begin selling SPE products directly into non-pharma application areas within the UK starting January 18, 2010. Sales to non-pharmaceutical based markets and customers have previously been managed by a distributor. "This is a logical ...
02-19-2009
Biotage announced that the company will enter the peptide synthesis business, through two new agreements with German company MultiSynTech GmbH. The agreements concern both the distribution rights for MultiSynTech's systems and the establishment of a joint development project. The agreements ...
01-26-2009
Biotage has made the decision to transfer instrument production from its Charlottesville, VA factory in the U.S. to a contract manufacturer. Through this decision, the company takes yet another step to increase efficiency in business activities. Biotage expects this measure to enable ...
03-06-2008
Biotage AB and McMaster University sign a two year extension to Molecular Imaging Development Agreement. McMaster University has successfully completed the first year research agreement, with a key journal publication and several technical presentations. "We used the Biotage Initiator ...
02-21-2008
Biotage AB announced plans to increase its focus on growing business opportunities in the environmental analysis business. The strategy includes redeployed marketing and sales resources along with new product development for specific application areas. In late 2007 Biotage launched EVOLUTE ...
06-21-2007
Molecular Imaging is an emerging market that is playing an important role to the ongoing worldwide efforts at improving health care and cost saving in the Pharma Industry. Biotage entered into a Molecular Imaging collaboration with McMaster University in February 2007 and it has ever since ...
02-28-2007
Biotage AB and McMaster University signed a joint agreement to develop a new chemistry platform to speed the production of molecular imaging and therapy agents. As part of the agreement, Biotage will provide funding and instruments. The McMaster Institute of Applied Radiation Sciences ...
03-02-2006
The life science company Biotage, listed on the O-list of the Stockholm stock exchange, makes a change in its top management. David Patteson, President of the business area Discovery Chemistry has decided to seek new challenges elsewhere. He will leave the company on 1 April 2006. David ...
